The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

George W. Sledge

Indiana University Simon Cancer Center

Indianapolis

Indiana

USA

[email]@iupui.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Indiana University Simon Cancer Center, Indianapolis, Indiana, USA. 2001 - 2010
  • Departments of Medicine and Pathology, Indiana University Cancer Center, Indianapolis, IN 46220, USA. 2006 - 2008
  • Indiana University Cancer Center, Indiana Cancer Pavilion, RT-473, 535 Barnhill Dr., USA. 2007
  • Cancer Pavillion, Indiana University Medical Center, 535 Barnhill Drive, Room RT473, USA. 2003
  • Indiana Cancer Pavilion, RT-473, 575 Barnhill Dr., Indianapolis, USA. 2001

References

  1. Heading in a new direction: drug permeability in breast cancer brain metastasis. Sledge, G.W. Clin. Cancer Res. (2010) [Pubmed]
  2. The new millennium for adjuvant therapy in breast cancer. Sledge, G.W. Oncology (Williston Park, N.Y.) (2008) [Pubmed]
  3. The evolution of targeted biologic therapies. Sledge, G.W. Breast (2007) [Pubmed]
  4. Protein kinase C-beta as a therapeutic target in breast cancer. Sledge, G.W., Gökmen-Polar, Y. Semin. Oncol. (2006) [Pubmed]
  5. VEGF-targeting therapy for breast cancer. Sledge, G.W. J. Mammary. Gland. Biol. Neoplasia (2005) [Pubmed]
  6. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). Sledge, G.W., Neuberg, D., Bernardo, P., Ingle, J.N., Martino, S., Rowinsky, E.K., Wood, W.C. J. Clin. Oncol. (2003) [Pubmed]
  7. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Sledge, G.W., Miller, K.D. Eur. J. Cancer (2003) [Pubmed]
  8. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer. Sledge, G.W. Oncology (Williston Park, N.Y.) (2003) [Pubmed]
  9. Is HER-2/neu a predictor of anthracycline utility? No. Sledge, G.W. J. Natl. Cancer Inst. Monographs (2001) [Pubmed]
  10. Breast cancer in the clinic: treatments past, treatments future. Sledge, G.W. J. Mammary. Gland. Biol. Neoplasia (2001) [Pubmed]
 
WikiGenes - Universities